(Q53549392)

15 May 2018

title

Extending Jak2V617F and MplW515 mutation analysis to single hematopoietic colonies and B and T lymphocytes. (English)

1 reference

15 May 2018

author

Rhett P. Ketterling

6

1 reference

15 May 2018

Ayalew Tefferi

8

object named as

Ayalew Tefferi

1 reference

15 May 2018

Animesh Pardanani

1

1 reference

15 May 2018

Terra L Lasho

2

1 reference

15 May 2018

Christy Finke

3

1 reference

15 May 2018

Ruben A Mesa

4

1 reference

15 May 2018

William J Hogan

5

1 reference

15 May 2018

Dwight Gary Gilliland

7

1 reference

15 May 2018

publication date

31 May 2007

1 reference

15 May 2018

published in

Stem Cells

1 reference

15 May 2018

volume

25

1 reference

15 May 2018

issue

9

1 reference

15 May 2018

page(s)

2358-2362

1 reference

15 May 2018

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

cites work

1 reference

https://api.crossref.org/works/10.1634%2FSTEMCELLS.2007-0175

MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1634%2FSTEMCELLS.2007-0175

X-inactivation-based clonality analysis and quantitative JAK2V617F assessment reveal a strong association between clonality and JAK2V617F in PV but not ET/MMM, and identifies a subset of JAK2V617F-negative ET and MMM patients with clonal hematopoies

21 January 2018

1 reference

https://api.crossref.org/works/10.1634%2FSTEMCELLS.2007-0175

MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1634%2FSTEMCELLS.2007-0175

The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1634%2FSTEMCELLS.2007-0175

JAK2V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1634%2FSTEMCELLS.2007-0175

Expression of Jak2V617F causes a polycythemia vera-like disease with associated myelofibrosis in a murine bone marrow transplant model

21 January 2018

1 reference

https://api.crossref.org/works/10.1634%2FSTEMCELLS.2007-0175

Molecular pathogenesis and therapy of polycythemia induced in mice by JAK2 V617F.

21 January 2018

1 reference

https://api.crossref.org/works/10.1634%2FSTEMCELLS.2007-0175

Characterization of murine JAK2V617F-positive myeloproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1634%2FSTEMCELLS.2007-0175

Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1634%2FSTEMCELLS.2007-0175

Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1634%2FSTEMCELLS.2007-0175

The World Health Organization (WHO) classification of the myeloid neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1634%2FSTEMCELLS.2007-0175

The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both "atypical" myeloproliferative disorders and myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1634%2FSTEMCELLS.2007-0175

JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1634%2FSTEMCELLS.2007-0175

JAK2T875N is a novel activating mutation that results in myeloproliferative disease with features of megakaryoblastic leukemia in a murine bone marrow transplantation model

21 January 2018

1 reference

https://api.crossref.org/works/10.1634%2FSTEMCELLS.2007-0175

Activating alleles of JAK3 in acute megakaryoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1634%2FSTEMCELLS.2007-0175

Polycythemia vera is not initiated by JAK2V617F mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1634%2FSTEMCELLS.2007-0175

Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera

21 January 2018

1 reference

https://api.crossref.org/works/10.1634%2FSTEMCELLS.2007-0175

The JAK2(V617F) tyrosine kinase mutation in myelofibrosis with myeloid metaplasia: lineage specificity and clinical correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1634%2FSTEMCELLS.2007-0175

10.1634/STEMCELLS.2007-0175

21 January 2018

Identifiers

DOI

1 reference

15 May 2018

1 reference

15 May 2018